Estimating costs for treating patients with multi-drug resistant tuberculosis (MDR TB) under the regional tuberculosis control program, Tomsk (Russia) Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015
Trend in TB control in Republic of Moldova: High MDRTB burden country Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014
Prevalence and trend of ofloxacin-resistance among MDR-TB including XDR-TB cases in Ukraine Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children Year: 2015
National evidence on the inefficiency of an inpatient model of tuberculosis management in Eastern Europe Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013
Rifampicin-resistant tuberculosis (RR-TB) in eastern Europe Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016
Nationwide anti-tuberculosis drug resistance survey in the Republic of Azerbaijan Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014
Tuberculosis and HIV infection in combination with multidrug resistant MBT on Northwest of Russia Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease Year: 2016
Characteristics of tuberculosis (TB) in patients that died from TB in Poland Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016
Multidrug-resistant and extensively drug resistance tuberculosis has a strong public health and economical impact in the Republic of Moldova Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013
Transmission pattern of MDR-TB in Singapore 2005-2015 Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016
The risk of default in TB patients in the Russian Federation Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2 Year: 2014
Effectiveness of national standardized and WHO regimens and risk factors of unfavorable outcomes in treatment of patients with MDR-TB in Novosibirsk Oblast, Russian Federation Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1 Year: 2014
Out-patient MDR-TB care in Moldova Source: International Congress 2015 – Management of TB: a patient focus Year: 2015
Tuberculosis (TB) in homeless population in Poland Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014
Dynamics analysis of MBT drug resistance to antitubercolosis second-line drugs (Saratov region hospital, Russia) Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016
Dynamics of MBT drug resistance in Saratov Region Hospital, Russia Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016
Impact of social support programme on MDR-TB patients' treatment outcomes Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3 Year: 2014
Four cases, one family: A cluster of resistant tuberculosis Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013
Risk factors for anti-TB drug resistance in Poland Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III Year: 2013